• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cynapsus Therapeutics Inc


Ticker Delisted

Snapshot for Cynapsus Therapeutics Inc (CYR1)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 0.296 - 0.943 1-Yr Rtn: -

Stock Chart for CYR1

No chart data available.
  • CYR1:GR 0.337
  • 1M
  • 1Y
Interactive CYR1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYR1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.1500
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYR1

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for CYR1

Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.

Anthony J GiovinazzoPresident/CEOAndrew Michael WilliamsCFO/COO
More Company Profile & Key Executives for CYR1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil